Profiel
Ana Radeljevic is Chief Executive Officer at Adventus Partners since 2016.
Ms. Radeljevic is Chief Business Officer at ADRx, Inc. since 2021.
Ms. Radeljevic was Independent Director at Merrimack Pharmaceuticals, Inc. from 2022 to 2025.
Ms. Radeljevic was Vice President-Financial Planning & Analysis at Revvity, Inc. from 2014 to 2016.
Ms. Radeljevic earned an MBA from Syracuse University and an undergraduate degree from Old Dominion University.
Actieve functies van Ana Radeljevic
| Bedrijven | Functie | Begin |
|---|---|---|
ADRx, Inc.
ADRx, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology drug discovery company focused on developing small-molecule therapies for neurodegenerative diseases | Corporate Officer/Principal | 01-09-2021 |
Eerdere bekende functies van Ana Radeljevic
| Bedrijven | Functie | Einde |
|---|---|---|
| MERRIMACK PHARMACEUTICALS | Directeur/Bestuurslid | 20-05-2025 |
| REVVITY, INC. | Corporate Officer/Principal | 01-01-2016 |
Opleiding van Ana Radeljevic
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Revvity, Inc.
Revvity, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes reagents, analytical instruments and develops software | Health Technology |
Merrimack Pharmaceuticals, Inc.
Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of immunological & autoimmune diseases and cancer | Health Technology |
Syracuse University
Syracuse University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Old Dominion University
Old Dominion University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ADRx, Inc.
ADRx, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology drug discovery company focused on developing small-molecule therapies for neurodegenerative diseases | Commercial Services |
















